<DOC>
	<DOCNO>NCT01435915</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetic profile ropinirole PR single multiple dos PR-formulation . It also investigate safety tolerability ropinirole PR single multiple dos PR-formulation .</brief_summary>
	<brief_title>Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<criteria>1 . Healthy adult men woman 18 45 year age , inclusive . 2 . Body weight &gt; =50Kg . 3 . Body Mass Index ( BMI ) 19 24 kg/m2 . 4 . No abnormality clinical examination . 5 . No abnormality reveal clinical chemistry haematology examination prestudy medical examination . 6 . A normal 12lead ECG prestudy screen . 7 . Normal systolic ( 100140mmHg ) diastolic ( &lt; 90mmHg ) blood pressure prestudy screen . 8 . Written inform consent prior admission study . 1 . Any clinically relevant abnormality identify screen history physical laboratory examination significant cardiovascular , neurological , psychiatric , haematological renal abnormality . 2 . Definite suspect personal history family history adverse reaction hypersensitivity study drug drug similar chemical structure . 3 . History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug . 4 . The subject receive prescribed medication within 7 day prior first dose day , opinion principal medical investigator interfere study procedure compromise safety . 5 . The subject receive overthecounter ( OTC ) medicine within 48 hour prior first study day . Subjects take OTC medication could still enter study , , opinion principal/coinvestigator , medication receive interfere study procedure compromise safety subject . 6 . Abuse alcohol , define average weekly intake great 21 unit average daily intake great three unit . One unit equivalent half pint beer , one measure spirit one glass wine . 7 . Positive screen addictive drug tobacco . 8 . Participation trial drug within 1 month start study . 9 . Either blood donation within previous 3 month , donation quantity blood within previous 12 month would result subject donate 1,500mL blood period 12 month study include end study . 10 . Positive prestudy screen result hepatitis B antigen , hepatitis C antibody HIV1/2 antibody . 11 . Pregnancy and/or lactation ; 12 . Female subject childbearing potential intending become pregnant and/or willing avoid pregnancy mean barrier contraception method ( i.e . condom IUD ) study 5 day prior screen 3 month follow study . 13 . Female subject positive serum hCG test result screen Days 1 study phase positive urine HCG test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>